You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
奇正藏藥(002287.SZ):子公司擬分別與控股股東簽訂商標使用許可合同
格隆匯 01-15 16:21

格隆匯 1 月 15日丨奇正藏藥(002287.SZ)公佈,因業務發展需要公司全資子公司甘肅奇正藏藥有限公司(“甘肅奇正)西藏奇正藏藥營銷有限公(西營銷)甘肅奇正藏藥營銷有限公司(甘肅營銷)分別甘肅奇正實業集團有限公司(“奇正集團”)簽訂《商標使用許可合同》,奇正集團許可甘肅奇正、西藏營銷、甘肅營銷分別無償使用商標號742166013888737個商標,西藏營銷許可奇正集團及其子公司無償使用129523237784667個商標公司股東大會審議通過後分別簽訂合同奇正集團為公司控股股東,此次交易構成關聯交易。

根據公司2019-2022一軸兩翼三支撐戰略,公司發展二、三梯隊極孵化新業務,此次商標交叉許可無償使用,為新業務的探索奠定基礎,有利於公司長遠發展

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account